Schedule 13G ownership disclosure

INOVIO PHARMACEUTICALS INC

Common Stock, par value $0.001 per share · CUSIP: 45773H409

Event date: 2024-12-31

Filing-level shares
3,633,333.00
Percent of class
9.2%
  • Highbridge Capital Management, LLC

    Shares: 3,633,333.00 · Class: 9.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-25-000808
Form type
SCHEDULE 13G
Filer
HIGHBRIDGE CAPITAL MANAGEMENT LLC
CIK
CIK 919185
Filed
Feb 10, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub